EdmundKingBartlettMD

PubMed

• Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
  Marchetti, M. A., Roger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, Serigne N Lo, Alexander C J van Akkooi, Daniel G Coit, Christian Ingvar, Karolin Isaksson,...> ;JAMA Surgery. 2024 Mar 1
• Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
  Harrison M Drebin, Nicholas R Kurtansky, Emily Nadelmann, Andrea P Moy, Charlotte E Ariyan, Danielle M Bello, Mary S Brady, Daniel G Coit, Michael A Marchetti, Edmund ...> ;Journal of the American College of Surgeons. 2024 Jan 1
• ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter?
  Kristen E Rhodin, Sin-Ho Jung, Kelly Elleson, Danielle DePalo, Richard Straker, Sophia McKinley, Kate Beekman, Lily Parker, Suephy Chen, Matthew K Iyer, April K S Sala...> ;Annals of Surgical Oncology. 2023 Oct 1
• 2 citations
  Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
  Kristen E Rhodin, Sin-Ho Jung, Kelly Elleson, Danielle DePalo, Richard Straker, Sophia McKinley, Kate Beekman, Lily Parker, Suephy Chen, Matthew K Iyer, April K S Sala...> ;Annals of Surgical Oncology. 2023 Oct 1
• 12 citations
  A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
  Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, Allison L Richards, Viswatej Avutu, Jason E Chan, Ping Chi, Mark A Dickson, Mrinal M Gounder, Mary Louise Keohan, Sujana...> ;Clinical Cancer Research. 2023 Jun 1
• ASO Visual Abstract: Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
  Zachary J Senders, Edmund K Bartlett, Tyler J Mouw, Kelly M McMasters, Michael E Egger> ;Annals of Surgical Oncology. 2023 Jun 1
• 2 citations
  Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.
  Israel S Kasago, Walid K Chatila, Cecilia M Lezcano, Christopher A Febres-Aldana, Nikolaus Schultz, Chad Vanderbilt, Snjezana Dogan, Edmund K Bartlett, Sandra P D'Ange...> ;Modern Pathology. 2023 Aug 1
• Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
  Zachary J Senders, Edmund K Bartlett, Tyler J Mouw, Kelly M McMasters, Michael E Egger> ;Annals of Surgical Oncology. 2023 Jun 1
• 7 citations
  Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
  Harrison M Drebin, Nicholas R Kurtansky, Roger Olofsson Bagge, Daniel G Coit, Edmund K Bartlett, Michael A Marchetti, Sharif Hosein> ;Journal of Surgical Oncology. 2023 Jun 1
• 1 citations
  Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2023 Mar 1
• A rare case of rhabdomyosarcoma identified in a VRAM flap after lower extremity reconstruction.
  Marlie H Fisher, Jack F C Woods, Edmund K Bartlett, Jonas A Nelson> ;Journal of Surgical Case Reports. 2023 Mar 1
• 7 citations
  Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study.
  Shannon, A., Sharon, C., Straker, R., Carr, M., Sinnamon, A., Bogatch, K., Thaler, A., Kelly, N., Vetto, J., Fowler, G., DePalo, D., Sondak, V., Miura, J., Faries, M.,...> ;Journal of the American Academy of Dermatology. 2023 Jan 1
• 6 citations
  Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis.
  Cimarron E Sharon, Richard J Straker 3rd, Phyllis A Gimotty, Emily Y Chu, Tara C Mitchell, John T Miura, Michael A Marchetti, Edmund K Bartlett, Giorgos C Karakousis> ;Journal of the American Academy of Dermatology. 2023 Apr 1
• 101 citations
  Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2022 Nov 1
• 3 citations
  Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma.
  Edmund K Bartlett, Avinash Sharma, Kenneth Seier, Cristina R Antonescu, Narasimhan P Agaram, Bhumika Jadeja, Evan Rosenbaum, Ping Chi, Murray F Brennan, Li-Xuan Qin, K...> ;JCO Precision Oncology. 2022 Oct 1
• 1 citations
  Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
  Kevin T Lynch, Yinin Hu, Norma E Farrow, Yun Song, Max O Meneveau, Minyoung Kwak, Michael C Lowe, Edmund K Bartlett, Georgia M Beasley, Giorgos C Karakousis, Craig L S...> ;Journal of Surgical Oncology. 2023 Jan 1
• 2 citations
  Management of pelvic sarcoma.
  Jay S Lee, Ciara M Kelly, Edmund K Bartlett> ;European Journal of Surgical Oncology. 2022 Nov 1
• 5 citations
  Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
  Eroglu, Z., Broman, K., Thompson, J., Nijhuis, A., Hieken, T., Kottschade, L., Farma, J., Hotz, M., Deneve, J., Fleming, M., Bartlett, E., Sharma, A., Dossett, L., Hug...> ;Journal for Immunotherapy of Cancer. 2022 Aug 1
• 10 citations
  Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
  Michael A Marchetti, Stephen W Dusza, Edmund K Bartlett> ;JAMA Dermatology. 2022 Jun 1
• ASO Visual Abstract: Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
  Edmund K Bartlett, Douglas Grossman, Susan M Swetter, Sancy A Leachman, Clara Curiel-Lewandrowski, Stephen W Dusza, Jeffrey E Gershenwald, John M Kirkwood, Amy L Tin, ...> ;Annals of surgical oncology. 2022 May 26
• 2 citations
  Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
  Edmund K Bartlett, Douglas Grossman, Susan M Swetter, Sancy A Leachman, Clara Curiel-Lewandrowski, Stephen W Dusza, Jeffrey E Gershenwald, John M Kirkwood, Amy L Tin, ...> ;Annals of Surgical Oncology. 2022 Sep 1
• 1 citations
  ASO Author Reflections: Why Treatment Risk Thresholds Are Needed for Patients with Melanoma.
  Edmund K Bartlett, Michael A Marchetti> ;Annals of Surgical Oncology. 2022 Sep 1
• 11 citations
  Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma.
  Nicholas D Klemen, Sinchun Hwang, Martina Bradic, Evan Rosenbaum, Mark A Dickson, Mrinal M Gounder, Ciara M Kelly, Mary L Keohan, Sujana Movva, Katherine A Thornton, P...> ;Clinical Cancer Research. 2022 Mar 1
• 6 citations
  International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Majo...
  Kristy K Broman, Tasha M Hughes, Brooke C Bredbeck, James Sun, Dennis Kirichenko, Michael J Carr, Avinash Sharma, Edmund K Bartlett, Amanda A G Nijhuis, John F Thompso...> ;Annals of Surgery. 2023 May 1
• 4 citations
  Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases.
  Edmund K. Bartlett, Sandra P. D'Angelo, Ciara Marie Kelly, Robert H Siegelbaum, Charles Fisher, Cristina R. Antonescu, Charlotte E. Ariyan> ;Frontiers in Oncology. 2021 Oct 15
• Join now to see all

Journal Articles

• Microsatellitosis in Patients with Melanoma  
  Richard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology